|
Market Closed -
Nasdaq Stockholm
16:30:00 30/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 16.22 SEK | -3.22% |
|
-5.92% | -28.23% |
| 10-27 | Synact Pharma enters commercial agreement with Brazilian company Hipolabor | FW |
| 10-27 | SynAct Pharma enters partnership agreement for resomelagon with Brazilian pharmaceutical company | FW |
Chart calendar SynAct Pharma AB
Upcoming events on SynAct Pharma AB
| 03/11/2026 | Earnings release - Q3 2026 | |
| 17/02/2027 | Earnings release - Annual 2026 |
Past events on SynAct Pharma AB
| 20/08/2026 | Earnings release - Q2 2026 | |
| 15/06/2026 | Information meeting | 12:00 |
| 11/06/2026 | Annual General Meeting | 13:00 |
| 27/05/2026 | Earnings release - Q1 2026 | |
| 11/03/2026 | Analyst/Investor Day | 18:00 |
| 18/02/2026 | Earnings release - Annual 2025 | |
| 27/11/2025 | Extraordinary General Meeting | 12:30 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 44,3 | 21,6 | 77,9 |
|
EBITDA Million SEK | Released Forecast Spread | -224 -160 -39.88% | -90,0 -92,0 2.2% | -117 -119 2.13% | -47,5 | -33,2 | 28,5 |
|
EBIT Million SEK | Released Forecast Spread | -224 -160 -39.88% | -90,0 -92,0 2.2% | -117 -119 2.4% | -47,8 | -33,3 | 28,5 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -224 -161 -39.39% | -90,8 -92,0 1.28% | -119 -121 1.79% | -51,2 | -34,8 | 28,5 |
|
Net income Million SEK | Released Forecast Spread | -216 -152 -41.58% | -82,4 -84,0 1.9% | -111 -113 1.96% | -47,1 | -31,9 | 28,5 |
|
EPS SEK | Released Forecast Spread | -6,64 -1,55 -329.02% | -2,08 -1,70 -22.35% | -2,17 -2,24 3.13% | -1,68 | -0,98 | 0,00 |
| Announcement Date | 23/02/24 | 18/02/25 | 18/02/26 | - |
Quarterly results
| Fiscal Period | June | 2025 Q1 | 2025 Q2 | 2025 Q3 |
|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBITDA Million SEK | Released Forecast Spread | -28,1 -26,0 -8.07% | ||
|
EBIT Million SEK | Released Forecast Spread | -28,1 -26,0 -8.07% | ||
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -30,3 -26,0 -16.64% | ||
|
Net income Million SEK | Released Forecast Spread | -24,7 -25,0 1.26% | ||
| Announcement Date | 27/05/25 | 18/08/25 | 30/10/25 |
| 02/11/2026 |  | Board of Directors Meeting | |
| 02/11/2026 | | Earnings release - Q2 2027 | |
| 02/11/2026 | | Earnings presentation | 16:30 |
| 02/11/2026 | | Extraordinary General Meeting | 11:30 |
| 02/11/2026 | | Board of Directors Meeting | |
| 02/11/2026 | | Earnings release - Q2 2027 | |
| 02/11/2026 | | Ex-dividend date - 75 IDR | 09:00 |
| 02/11/2026 | | Earnings presentation | 10:00 |
| 03/11/2026 | | Earnings presentation | 19:00 |
| 03/11/2026 | | Earnings release - Q3 2026 |
Past sector events for SynAct Pharma AB
| Today | | Earnings release - Q3 2026 | |
| Today | | Earnings release - Q3 2026 | |
| Today | | Earnings release - Q3 2026 | |
| Today | | Earnings release - Q3 2026 | |
| Today | | Earnings release - Q3 2026 | |
| Today | | Earnings release - Q3 2026 | |
| Today | | Earnings release - Q3 2026 | |
| Today | | Earnings release - Q3 2026 | |
| Today | | Earnings release - Q3 2026 | |
| Today | | Earnings release - Q3 2026 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SYNACT Stock
- Calendar SynAct Pharma AB
Select your edition
All financial news and data tailored to specific country editions
